Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy and safety of Cadonilimab Injection in combination with Regorafenib in the treatment of intermediate to advanced biliary systemic tumours that has failed at least one prior systemic therapy


Clinical Trial Description

An open, single-arm, single-centre clinical study evaluating Cadonilimab Injection in combination with Regorafenib for the treatment of biliary systemic tumours that have failed at least one prior systemic therapy ;


Study Design


NCT number NCT05644392
Study type Interventional
Source Tianjin Medical University Cancer Institute and Hospital
Contact Huikai Li, MD
Phone 18622228639
Email tjchlhk@126.com
Status Recruiting
Phase Phase 1
Start date November 25, 2022
Completion date November 25, 2025